Eric Crombez

Eric Crombez

Company: Ultragenyx

Job title: Chief Medical Officer


Eric Crombez is a board-certified clinical geneticist with extensive experience in the development and execution of clinical development programs for rare genetic disorders. Dr. Crombez currently serves as the Chief Medical Officer for Ultragenyx Gene Therapy and Inborn Errors of Metabolism, and leads clinical development efforts for the multiple preclinical and clinical stage gene therapy programs in Ultragenyx’s pipeline. Dr. Crombez also serves as an Industry Representative on the FDA Cellular, Tissue, and Gene Therapies Advisory Committee.   

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.